Folgen
Payam Mohammadinejad
Payam Mohammadinejad
Tehran University of Medical Sciences
Bestätigte E-Mail-Adresse bei mayo.edu
Titel
Zitiert von
Zitiert von
Jahr
Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry
A Aghamohammadi, P Mohammadinejad, H Abolhassani, B Mirminachi, ...
Journal of clinical immunology 34, 478-490, 2014
1512014
Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double‐blind, placebo‐controlled trial
S Arabzadeh, N Ameli, A Zeinoddini, F Rezaei, M Farokhnia, ...
Bipolar disorders 17 (6), 606-614, 2015
992015
Autoimmune phenotype in patients with common variable immunodeficiency
H Abolhassani, D Amirkashani, N Parvaneh, P Mohammadinejad, ...
J Investig Allergol Clin Immunol 23 (5), 323-9, 2013
782013
Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial
H Emadi-Kouchak, P Mohammadinejad, A Asadollahi-Amin, ...
International clinical psychopharmacology 31 (1), 20-26, 2016
762016
Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial
SH Abbasi, P Mohammadinejad, N Shahmansouri, A Salehiomran, ...
Journal of Affective Disorders 183, 149-155, 2015
682015
Celecoxib as an adjuvant to fluvoxamine in moderate to severe obsessive-compulsive disorder: a double-blind, placebo-controlled, randomized trial
M Shalbafan, P Mohammadinejad, SV Shariat, K Alavi, A Zeinoddini, ...
Pharmacopsychiatry 48 (04/05), 136-140, 2015
672015
Carotid artery corrected flow time measurement via bedside ultrasonography in monitoring volume status
H Hossein-Nejad, P Mohammadinejad, M Lessan-Pezeshki, SS Davarani, ...
Journal of critical care 30 (6), 1199-1203, 2015
582015
Riluzole in augmentation of fluvoxamine for moderate to severe obsessive–compulsive disorder: R andomized, double‐blind, placebo‐controlled study
S Emamzadehfard, A Kamaloo, K Paydary, A Ahmadipour, A Zeinoddini, ...
Psychiatry and Clinical Neurosciences 70 (8), 332-341, 2016
552016
8 Pediatric Patients With Common Variable Immunodeficiency: Long-term Follow-up
P Mohammadinejad, A Aghamohammadi, H Abolhassani, MS Sadaghiani, ...
Journal of Investigational Allergology and Clinical Immunology 22 (3), 208, 2012
512012
The difference between computed tomography and magnetic resonance imaging measurements of tibial tubercle–trochlear groove distance for patients with or without patellofemoral …
SHS Tan, BY Lim, KSJ Chng, C Doshi, FKL Wong, AKS Lim, JH Hui
The Journal of Knee Surgery 33 (08), 768-776, 2020
502020
Riluzole combination therapy for moderate-to-severe major depressive disorder: a randomized, double-blind, placebo-controlled trial
E Salardini, A Zeinoddini, P Mohammadinejad, MR Khodaie-Ardakani, ...
Journal of psychiatric research 75, 24-30, 2016
502016
Celecoxib versus diclofenac in mild to moderate depression management among breast cancer patients: A double-blind, placebo-controlled, randomized trial
P Mohammadinejad, P Arya, M Esfandbod, A Kaviani, M Najafi, L Kashani, ...
Annals of Pharmacotherapy 49 (9), 953-961, 2015
502015
CT noise-reduction methods for lower-dose scanning: strengths and weaknesses of iterative reconstruction algorithms and new techniques
P Mohammadinejad, A Mileto, L Yu, S Leng, LS Guimaraes, AD Missert, ...
Radiographics 41 (5), 1493-1508, 2021
492021
Minocycline as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind placebo-controlled trial
A Ghaleiha, R Alikhani, MR Kazemi, MR Mohammadi, ...
Journal of child and adolescent psychopharmacology 26 (9), 784-791, 2016
492016
Primary antibody deficiency in a tertiary referral hospital: a 30-year experiment.
P Mohammadinejad, S Pourhamdi, H Abolhassani, B Mirminachi, ...
Journal of investigational allergology & clinical immunology 25 (6), 416-425, 2015
462015
The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double‐blind and placebo‐controlled trial
N Iranpour, A Zandifar, M Farokhnia, A Goguol, H Yekehtaz, ...
Human Psychopharmacology: Clinical and Experimental 31 (2), 103-112, 2016
452016
The approach to children with recurrent infections
A Aghamohammadi, H Abolhassani, P Mohammadinejad, N Rezaei
Iranian Journal of Allergy, Asthma and Immunology 11 (2), 89, 2012
432012
A randomized, double-blind placebo-controlled trial on effectiveness and safety of celecoxib adjunctive therapy in adolescents with acute bipolar mania
SY Mousavi, R Khezri, MA Karkhaneh-Yousefi, P Mohammadinejad, ...
Journal of Child and Adolescent Psychopharmacology 27 (6), 494-500, 2017
372017
Effect of memantine combination therapy on symptoms in patients with moderate‐to‐severe depressive disorder: randomized, double‐blind, placebo‐controlled study
M Amidfar, M Khiabany, A Kohi, E Salardini, M Arbabi, M Roohi Azizi, ...
Journal of clinical pharmacy and therapeutics 42 (1), 44-50, 2017
372017
Malignancy phenotype in common variable immunodeficiency.
H Abolhassani, A Aghamohammadi, A Imanzadeh, P Mohammadinejad, ...
Journal of investigational allergology & clinical immunology 22 (2), 133-134, 2012
372012
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20